Professional Documents
Culture Documents
Gentlemen :
This refers to your letter, dated December 7, 1988, requesting for opinion of
this Commission on the query posed therein. prcd
All stockholders of record of the Hospital were given the pre-emptive right
to subscribe to 20 shares at P10,000.00 per share; all were specifically given a
deadline within which to indicate whether or not they were subscribing to the
increase in the authorized capital stock, and upon failure thereof, they would be
deemed to have waived their pre-emptive right to such increase. Quite a number of
medical stockholders indicated their willingness to subscribe; some unequivocably
waived their pre-emptive right, while still others chose to ignore the request for
subscription or express waiver.
Copyright 1994-2018 CD Technologies Asia, Inc. Securities and Exchange Commission 2018 1
medical clinics within the Hospital premises. They may however continue to bring
in patients for confinement at the Hospital as visiting physicians.
Hence, your query is: whether or not the board resolution limiting the use of
Hospital premises for medical clinics exclusively to medical stockholders who
subscribe and pay in full the shares allotted to them out of the increase in the
authorized capital stock is legally feasible.
On the basis or the facts above presented the following information may be
imparted:
It is, therefore, opined that said resolution of the board limiting the use of
Hospital premises for medical clinics only to medical stockholders who subscribed
and pay in full the shares allotted to them out of the increase in the authorized
capital stock is legally justifiable provided that the following conditions are met:
"(1) management acts in a good faith belief that its decision is in the company's
best interests; (2) it exercises due care in ascertaining relevant facts and law before
making the decision; and (3) it has no personal interest in the transaction". (3A
Fletcher Cyc. Corp., 1986 rev. vol., sec. 1040, p. 58). prcd
Copyright 1994-2018 CD Technologies Asia, Inc. Securities and Exchange Commission 2018 3